Results of a phase III, double-blind, placebo-controlled trial of megestrol acetate modulation of P glycoprotein-mediated drug resistance in the first-line management of small-cell lung carcinoma

TY - JOUR

T1 - Results of a phase III, double-blind, placebo-controlled trial of megestrol acetate modulation of P glycoprotein-mediated drug resistance in the first-line management of small-cell lung carcinoma

AU - Wood, L.

AU - Palmer, M.

AU - Hewitt, J.

AU - Urtasun, R.

AU - Bruera, E.

AU - Rapp, E.

AU - Thaell, J. F.

PY - 1998

Y1 - 1998

KW - Drug resistance

KW - Megestrol acetate

KW - P-glycoprotein

KW - Small-cell lung cancer

UR - http://www.scopus.com/inward/record.url?scp=0031963639&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031963639&partnerID=8YFLogxK

U2 - 10.1038/bjc.1998.100

DO - 10.1038/bjc.1998.100

M3 - Article

C2 - 9484821

AN - SCOPUS:0031963639

SN - 0007-0920

VL - 77

SP - 627

EP - 631

JO - British Journal of Cancer

JF - British Journal of Cancer

IS - 4

ER -